AnaptysBio, Inc.
ANAB
$59.43
-$0.56-0.93%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 286.46M | 311.64M | 248.96M | 265.71M | 339.94M |
| Total Receivables | 25.75M | 33.85M | 75.69M | 21.42M | 17.88M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.91M | 4.76M | 6.01M | 4.78M | 5.29M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 316.11M | 350.25M | 330.65M | 291.91M | 363.11M |
|
|
|||||
| Total Current Assets | 316.11M | 350.25M | 330.65M | 291.91M | 363.11M |
| Net Property, Plant & Equipment | 13.32M | 13.89M | 14.49M | 15.09M | 15.66M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 256.00K | 256.00K | 256.00K | 256.00K | 256.00K |
| Total Assets | 329.68M | 364.40M | 353.10M | 335.25M | 422.05M |
|
|
|||||
| Total Accounts Payable | 7.52M | 3.87M | 2.89M | 3.33M | 6.12M |
| Total Accrued Expenses | 31.68M | 32.29M | 32.62M | 29.72M | 31.45M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.12M | 2.08M | 2.04M | 2.00M | 1.96M |
| Total Finance Division Other Current Liabilities | 382.00K | 382.00K | 554.00K | 480.00K | 4.50M |
| Total Other Current Liabilities | 382.00K | 382.00K | 554.00K | 480.00K | 4.50M |
| Total Current Liabilities | 41.70M | 38.63M | 38.10M | 35.53M | 44.04M |
|
|
|||||
| Total Current Liabilities | 41.70M | 38.63M | 38.10M | 35.53M | 44.04M |
| Long-Term Debt | 263.74M | 276.53M | 331.84M | 331.36M | 330.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 11.49M | 12.03M | 12.57M | 13.10M | 13.61M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 316.94M | 327.19M | 382.51M | 379.98M | 388.03M |
|
|
|||||
| Common Stock & APIC | 838.34M | 809.79M | 792.71M | 792.56M | 832.52M |
| Retained Earnings | -825.44M | -772.56M | -822.17M | -837.29M | -798.66M |
| Treasury Stock & Other | -146.00K | -24.00K | 47.00K | -6.00K | 161.00K |
| Total Common Equity | 12.75M | 37.21M | -29.42M | -44.73M | 34.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.75M | 37.21M | -29.42M | -44.73M | 34.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.75M | 37.21M | -29.42M | -44.73M | 34.02M |
|
|
|||||